The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 7
  • 1
    Kearns, Shay
    Sr. Finance Director born in December 1977
    Individual (2 offsprings)
    Officer
    2024-06-15 ~ now
    OF - Director → CIF 0
  • 2
    Parish, Sean Peter
    Vp Finance, Asia Pacific born in January 1974
    Individual (5 offsprings)
    Officer
    2014-03-18 ~ now
    OF - Director → CIF 0
  • 3
    Kilbane, Seamus Gearoid, Mr
    Sr. Finance Director born in April 1964
    Individual (2 offsprings)
    Officer
    2024-06-15 ~ now
    OF - Director → CIF 0
  • 4
    Greet, David John, Mr
    Operations Director born in September 1975
    Individual (2 offsprings)
    Officer
    2024-06-15 ~ now
    OF - Director → CIF 0
  • 5
    Mackay, Kimberly Banks, Mrs
    General Counsel born in July 1965
    Individual (2 offsprings)
    Officer
    2024-06-15 ~ now
    OF - Director → CIF 0
  • 6
    WEST PHARMACEUTICAL SERVICES GROUP LIMITED - now
    THE WEST COMPANY GROUP LIMITED - 1999-03-04
    WEST PHARMA GROUP LIMITED - 1995-06-30
    BARDEP 111 LIMITED - 1989-10-26
    25, Bucklers Lane, St. Austell, England
    Active Corporate (8 parents, 1 offspring)
    Equity (Company account)
    12,523,000 GBP2023-12-31
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
  • 7
    NET SEARCHERS INTERNATIONAL LTD. - 2008-07-16
    C/o Corporation Service Company (uk) Limited, 5 Churchill Place, 10th Floor, London, United Kingdom
    Active Corporate (5 parents, 547 offsprings)
    Officer
    2023-04-18 ~ now
    OF - Secretary → CIF 0
Ceased 23
  • 1
    Littler, William
    Vp Finance Europe born in December 1942
    Individual
    Officer
    1999-11-01 ~ 2005-04-30
    OF - Director → CIF 0
  • 2
    Parish, Sean Peter
    Individual (5 offsprings)
    Officer
    2003-01-28 ~ 2014-03-18
    OF - Secretary → CIF 0
  • 3
    Thornton, Paul John
    Individual (2 offsprings)
    Officer
    2019-11-22 ~ 2021-07-31
    OF - Secretary → CIF 0
  • 4
    Pope, Darren
    Individual (1 offspring)
    Officer
    2014-03-18 ~ 2019-11-22
    OF - Secretary → CIF 0
  • 5
    Dudart Aberdeen, Adrian Paul
    Individual
    Officer
    2002-04-15 ~ 2003-01-28
    OF - Secretary → CIF 0
  • 6
    Grose, Ellen Yvette
    Operations Director born in July 1970
    Individual
    Officer
    2016-12-05 ~ 2024-06-30
    OF - Director → CIF 0
  • 7
    Bushey, Rachel
    Assistant General Counsel born in October 1977
    Individual
    Officer
    2013-06-13 ~ 2014-07-27
    OF - Director → CIF 0
  • 8
    Gailey Iii, John Robert
    Attorney born in December 1954
    Individual (2 offsprings)
    Officer
    ~ 2013-06-13
    OF - Director → CIF 0
  • 9
    Kemper, Martin Jozef Hubert, Dr
    Operations Manager born in July 1951
    Individual
    Officer
    1995-09-30 ~ 1999-10-29
    OF - Director → CIF 0
  • 10
    Smith, Anthony
    Director Of Operations born in October 1976
    Individual (1 offspring)
    Officer
    2014-03-18 ~ 2016-12-05
    OF - Director → CIF 0
  • 11
    Van Dijk, Ron
    Director born in March 1960
    Individual
    Officer
    2005-04-30 ~ 2006-11-29
    OF - Director → CIF 0
  • 12
    Baughman, Mickey Allen
    Operations Director born in August 1940
    Individual
    Officer
    1996-02-26 ~ 2001-05-31
    OF - Director → CIF 0
  • 13
    Gold, Oskar Wilhelm
    Sales Director Europe born in July 1955
    Individual
    Officer
    1996-05-24 ~ 1999-10-29
    OF - Director → CIF 0
  • 14
    Bath, John Roche
    Regional Director born in March 1952
    Individual (1 offspring)
    Officer
    1996-12-04 ~ 1998-04-30
    OF - Director → CIF 0
  • 15
    Lennartz, Heino
    Director born in August 1965
    Individual (2 offsprings)
    Officer
    2006-12-01 ~ 2018-03-31
    OF - Director → CIF 0
  • 16
    Selke, Stephan, Dr
    Vice President - Finance born in March 1967
    Individual
    Officer
    2016-12-05 ~ 2024-04-30
    OF - Director → CIF 0
  • 17
    Brame, Gerry
    Director born in February 1964
    Individual (2 offsprings)
    Officer
    2005-05-01 ~ 2006-03-08
    OF - Director → CIF 0
  • 18
    Chilvers, Anthony
    Director Of Operations born in July 1947
    Individual
    Officer
    2001-06-01 ~ 2002-08-01
    OF - Director → CIF 0
    Chilvers, Anthony
    Individual
    Officer
    ~ 2002-04-15
    OF - Secretary → CIF 0
  • 19
    Wimmer, Hans
    Director born in October 1929
    Individual
    Officer
    ~ 1995-06-30
    OF - Director → CIF 0
  • 20
    Miller, George Lloyd
    Corporate Secretary born in January 1955
    Individual
    Officer
    2016-12-05 ~ 2021-02-28
    OF - Director → CIF 0
  • 21
    Elliott, David
    Vp Finance born in May 1957
    Individual
    Officer
    2011-10-27 ~ 2016-12-05
    OF - Director → CIF 0
  • 22
    Tychsen, Ulf Christian
    Born in October 1944
    Individual
    Officer
    1992-12-17 ~ 1996-03-27
    OF - Director → CIF 0
  • 23
    Griffiths, Alan David
    Director born in February 1939
    Individual
    Officer
    ~ 1995-09-30
    OF - Director → CIF 0
parent relation
Company in focus

WEST PHARMACEUTICAL SERVICES CORNWALL LIMITED

Previous names
THE WEST COMPANY (UK) LIMITED - 1999-03-04
PHARMA-GUMMI (UK) LIMITED - 1995-06-30
WEST PHARMARUBBER LIMITED - 1994-01-11
Standard Industrial Classification
21100 - Manufacture Of Basic Pharmaceutical Products
Brief company account
Turnover/Revenue
53,566,000 GBP2023-01-01 ~ 2023-12-31
54,924,000 GBP2022-01-01 ~ 2022-12-31
Cost of Sales
-45,161,000 GBP2023-01-01 ~ 2023-12-31
-43,976,000 GBP2022-01-01 ~ 2022-12-31
Gross Profit/Loss
8,405,000 GBP2023-01-01 ~ 2023-12-31
10,948,000 GBP2022-01-01 ~ 2022-12-31
Distribution Costs
-1,221,000 GBP2023-01-01 ~ 2023-12-31
-1,100,000 GBP2022-01-01 ~ 2022-12-31
Administrative Expenses
-1,190,000 GBP2023-01-01 ~ 2023-12-31
-3,503,000 GBP2022-01-01 ~ 2022-12-31
Operating Profit/Loss
5,994,000 GBP2023-01-01 ~ 2023-12-31
6,345,000 GBP2022-01-01 ~ 2022-12-31
Other Interest Receivable/Similar Income (Finance Income)
473,000 GBP2023-01-01 ~ 2023-12-31
31,000 GBP2022-01-01 ~ 2022-12-31
Profit/Loss on Ordinary Activities Before Tax
6,510,000 GBP2023-01-01 ~ 2023-12-31
6,362,000 GBP2022-01-01 ~ 2022-12-31
Profit/Loss
5,764,000 GBP2023-01-01 ~ 2023-12-31
5,475,000 GBP2022-01-01 ~ 2022-12-31
Comprehensive Income/Expense
5,764,000 GBP2023-01-01 ~ 2023-12-31
5,475,000 GBP2022-01-01 ~ 2022-12-31
Property, Plant & Equipment
11,405,000 GBP2023-12-31
10,066,000 GBP2022-12-31
Total Inventories
3,142,000 GBP2023-12-31
3,070,000 GBP2022-12-31
Debtors
8,152,000 GBP2023-12-31
6,733,000 GBP2022-12-31
Cash at bank and in hand
19,192,000 GBP2023-12-31
19,963,000 GBP2022-12-31
Current Assets
30,486,000 GBP2023-12-31
29,766,000 GBP2022-12-31
Net Current Assets/Liabilities
22,353,000 GBP2023-12-31
17,333,000 GBP2022-12-31
Total Assets Less Current Liabilities
33,758,000 GBP2023-12-31
27,399,000 GBP2022-12-31
Net Assets/Liabilities
32,837,000 GBP2023-12-31
27,073,000 GBP2022-12-31
Equity
Called up share capital
12,293,000 GBP2023-12-31
12,293,000 GBP2022-12-31
12,293,000 GBP2021-12-31
Retained earnings (accumulated losses)
20,544,000 GBP2023-12-31
14,780,000 GBP2022-12-31
9,305,000 GBP2021-12-31
Equity
32,837,000 GBP2023-12-31
27,073,000 GBP2022-12-31
21,598,000 GBP2021-12-31
Profit/Loss
Retained earnings (accumulated losses)
5,764,000 GBP2023-01-01 ~ 2023-12-31
5,475,000 GBP2022-01-01 ~ 2022-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
5,475,000 GBP2022-01-01 ~ 2022-12-31
Property, Plant & Equipment - Depreciation Expense
1,211,000 GBP2023-01-01 ~ 2023-12-31
936,000 GBP2022-01-01 ~ 2022-12-31
Wages/Salaries
8,103,000 GBP2023-01-01 ~ 2023-12-31
8,594,000 GBP2022-01-01 ~ 2022-12-31
Social Security Costs
890,000 GBP2023-01-01 ~ 2023-12-31
905,000 GBP2022-01-01 ~ 2022-12-31
Staff Costs/Employee Benefits Expense
9,737,000 GBP2023-01-01 ~ 2023-12-31
9,967,000 GBP2022-01-01 ~ 2022-12-31
Average number of employees in administration and support functions
37,0002023-01-01 ~ 2023-12-31
40,0002022-01-01 ~ 2022-12-31
Average Number of Employees
2080002023-01-01 ~ 2023-12-31
2150002022-01-01 ~ 2022-12-31
Director Remuneration
230,000 GBP2023-01-01 ~ 2023-12-31
174,000 GBP2022-01-01 ~ 2022-12-31
Audit Fees/Expenses
40,000 GBP2023-01-01 ~ 2023-12-31
36,000 GBP2022-01-01 ~ 2022-12-31
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
635,000 GBP2023-01-01 ~ 2023-12-31
887,000 GBP2022-01-01 ~ 2022-12-31
Tax Expense/Credit at Applicable Tax Rate
1,531,000 GBP2023-01-01 ~ 2023-12-31
1,209,000 GBP2022-01-01 ~ 2022-12-31
Deferred Tax Liabilities
Accelerated tax depreciation
226,000 GBP2022-12-31
Deferred Tax Liabilities
226,000 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
Land and buildings
8,492,000 GBP2023-12-31
7,933,000 GBP2022-12-31
Tools/Equipment for furniture and fittings
15,183,000 GBP2023-12-31
12,670,000 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
25,589,000 GBP2023-12-31
23,489,000 GBP2022-12-31
Property, Plant & Equipment - Disposals
Land and buildings
-4,000 GBP2023-01-01 ~ 2023-12-31
Tools/Equipment for furniture and fittings
-450,000 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Disposals
-454,000 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Land and buildings
5,750,000 GBP2023-12-31
5,502,000 GBP2022-12-31
Tools/Equipment for furniture and fittings
8,434,000 GBP2023-12-31
7,921,000 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
14,184,000 GBP2023-12-31
13,423,000 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Land and buildings
251,000 GBP2023-01-01 ~ 2023-12-31
Tools/Equipment for furniture and fittings
963,000 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
1,214,000 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Decrease in depreciation and impairment related to disposals
Land and buildings
-3,000 GBP2023-01-01 ~ 2023-12-31
Tools/Equipment for furniture and fittings
-450,000 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Decrease in depreciation and impairment related to disposals
-453,000 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment
Land and buildings
2,742,000 GBP2023-12-31
2,431,000 GBP2022-12-31
Tools/Equipment for furniture and fittings
6,749,000 GBP2023-12-31
4,749,000 GBP2022-12-31
Raw materials and consumables
988,000 GBP2023-12-31
824,000 GBP2022-12-31
Value of work in progress
1,479,000 GBP2023-12-31
1,050,000 GBP2022-12-31
Finished Goods/Goods for Resale
675,000 GBP2023-12-31
1,196,000 GBP2022-12-31
Trade Debtors/Trade Receivables
4,491,000 GBP2023-12-31
5,364,000 GBP2022-12-31
Amounts Owed By Related Parties
3,259,000 GBP2023-12-31
884,000 GBP2022-12-31
Other Debtors
273,000 GBP2023-12-31
439,000 GBP2022-12-31
Debtors
Current
8,152,000 GBP2023-12-31
6,733,000 GBP2022-12-31
Total Borrowings
Current, Amounts falling due within one year
49,000 GBP2022-12-31
Trade Creditors/Trade Payables
2,008,000 GBP2023-12-31
1,368,000 GBP2022-12-31
Amounts Owed to Related Parties
2,842,000 GBP2023-12-31
3,754,000 GBP2022-12-31
Taxation/Social Security Payable
532,000 GBP2023-12-31
1,264,000 GBP2022-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
57,000 GBP2023-12-31
52,000 GBP2022-12-31
Between two and five year
57,000 GBP2023-12-31
107,000 GBP2022-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
114,000 GBP2023-12-31
159,000 GBP2022-12-31
Amounts set aside to cover potential liabilities or losses
Deferred taxation
861,000 GBP2023-12-31
226,000 GBP2022-12-31
Par Value of Share
Class 1 ordinary share
12023-01-01 ~ 2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
12,293,000 shares2023-12-31
12,293,000 shares2022-12-31
  • WEST PHARMACEUTICAL SERVICES CORNWALL LIMITED
    Info
    THE WEST COMPANY (UK) LIMITED - 1999-03-04
    PHARMA-GUMMI (UK) LIMITED - 1995-06-30
    WEST PHARMARUBBER LIMITED - 1994-01-11
    Registered number 00930319
    C/o Corporation Service Company (uk) Limited, 5 Churchill Place, 10th Floor, London E14 5HU
    Private Limited Company incorporated on 1968-04-09 (57 years 3 months). The company status is Active.
    The last date of confirmation statement was made at 2024-09-30
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.